TABLE 2.
DRD4 | DRD2 | D4/D2 | α1 | ||
---|---|---|---|---|---|
Pipamperone | 5.1 | 120.0 | 0.04 | 66.0 | Li et al. 96 |
Clozapine | 40.0 | 152.0 | 0.26 | 123.0 | Schotte et al. 97 |
63.0 | 72.0 | 0.86 | 109.0 | Ishiyama et al. 98 | |
47.0 | 125.0 | 0.38 | – | Bymaster et al. 100 | |
13.0 | 74.0 | 0.17 | – | Patel et al. 102 | |
Asenapine | 1.1 | 1.3 | 0.85 | 1.2 | Stoner et al. 99 |
Olanzapine | 21.0 | 72.0 | 0.29 | 109.0 | Ishiyama et al. 98 |
26.0 | 11.0 | 2.36 | – | Bymaster et al. 100 | |
57.3 | 10.5 | 5.46 | – | Rasmussen et al. 101 | |
Perospirone | 1.8 | 1.3 | 1.38 | 2.5 | Schotte et al. 97 |
Mosapramine | 3.2 | 1.8 | 1.66 | 43.0 | Schotte et al. 97 |
Risperidone | 16.0 | 3.3 | 4.84 | 2.3 | Schotte et al. 97 |
7.5 | 4.9 | 1.53 | 5.0 | Ishiyama et al. 98 | |
Haloperidol | 15.0 | 2.0 | 7.50 | – | Li et al. 96 |
11.0 | 1.4 | 7.80 | 19.0 | Schotte et al. 97 | |
5.0 | 2.0 | 2.50 | 12.0 | Ishiyama et al. 98 | |
1.6 | 1.0 | 1.60 | – | Bymaster et al. 100 | |
2.3 | 1.4 | 1.64 | – | Patel et al. 102 | |
Spiperone | 1.4 | 0.053 | 26.40 | 25.0 | Li et al. 96 |